Estimating the Population Impact of Introducing Stereotactic Ablative Radiation Therapy for Stage I NSCLC in Canada

被引：0
|
作者：
Louie, A. V. [1 ,2 ]
Rodrigues, G. [3 ]
Palma, D. A. [3 ]
Senan, S. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[3] London Reg Canc Program, London, ON, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.1767
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2959
引用
收藏
页码：S588 / S588
页数：1
相关论文
共 50 条
  • [1] MEASURING THE POPULATION IMPACT OF INTRODUCING STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR STAGE I NSCLC IN CANADA
    Louie, A. V.
    Rodrigues, G. B.
    Palma, D. A.
    Senan, S.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S15 - S16
  • [2] Measuring the Population Impact of Introducing Stereotactic Ablative Radiotherapy for Stage I Non-Small Cell Lung Cancer in Canada
    Louie, Alexander V.
    Rodrigues, George B.
    Palma, David A.
    Senan, Suresh
    ONCOLOGIST, 2014, 19 (08): : 880 - 885
  • [3] Improved Outcomes in Stage I NSCLC Patients Treated in the Stereotactic Ablative Radiation Therapy Era: A Population-based Analysis
    Trakul, N.
    Murphy, J. D.
    Loo, B. W.
    Diehn, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S608 - S608
  • [4] Stereotactic ablative radiotherapy for inoperable stage I NSCLC
    Andratschke, Nicolaus
    LANCET ONCOLOGY, 2012, 13 (08): : 746 - 748
  • [5] Management of Stage I Lung Cancer with Stereotactic Ablative Radiation Therapy
    Dan, Tu
    Williams, Noelle L.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 26 (03) : 393 - +
  • [6] ROLE OF STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN STAGE I NSCLC
    Slotman, Ben
    Lagerwaard, Frank
    Haasbeek, Niels
    Verstegen, Naomi
    Dahele, Max
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S103 - S103
  • [7] Partial Stereotactic Ablative Boost Radiation Therapy In Bulky NSCLC
    Bai, Y.
    Gao, X.
    Qin, S.
    Chen, J.
    Su, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E673 - E673
  • [8] Implementation Plan for Stereotactic Body Radiation Therapy in Stage I NSCLC
    Lilley, J.
    Franks, K.
    Naisbit, M.
    Stanley, S.
    Kirwin, S.
    Cosgrove, V.
    CLINICAL ONCOLOGY, 2009, 21 (03) : 272 - 273
  • [9] Stereotactic Ablative Radiotherapy (SABR) For Pathologically Confirmed Stage I NSCLC
    Lagerwaard, F. J.
    Verstegen, N. E.
    Haasbeek, C. J. A.
    Slotman, B. J.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S599 - S600
  • [10] Stereotactic ablative Radiotherapy confirmed as a Standard Technique in NSCLC Stage I
    Hecht, Markus
    Fietkau, Rainer
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (10) : 945 - 947
12345